The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Immunogenicity of sipuleucel-T (Sip-T) in abiraterone (Abi)/enzalutamide (Enz) sensitive and resistant metastatic castrate-resistant prostate cancer (mCRPC).
 
Eric Jay Small
No Relationships to Disclose
 
Lawrence Fong
Research Funding - Abbvie (Inst); Bristol-Myers Squibb (Inst); Dendreon (Inst); Oncosec (Inst); Roche/Genentech (Inst)
 
David I. Quinn
Honoraria - Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; Fresenius Kabi; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Consulting or Advisory Role - Algeta/Bayer; Astellas Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
Expert Testimony - Medivation; Teva
 
Charles G. Drake
Stock and Other Ownership Interests - Compugen; NexImmune; Potenza Therapeutics; Tizona Therapeutics, Inc.
Consulting or Advisory Role - Agenus; Dendreon; ImmuneXcite; Janssen-Ortho; Lilly; Merck; NexImmune; Pierre Fabre; Roche/Genentech
Research Funding - Aduro Biotech; Bristol-Myers Squibb; Janssen-Ortho
Patents, Royalties, Other Intellectual Property - AZ Medimmune; Bristol-Myers Squibb; Janssen
 
Dwayne Campogan
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Tuyen Vu
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Nadeem Anwar Sheikh
Employment - Valeant Pharmaceuticals International
Stock and Other Ownership Interests - Valeant Pharmaceuticals International
Patents, Royalties, Other Intellectual Property - Dendreon
 
Nancy N. Chang
Employment - Dendreon
Stock and Other Ownership Interests - Dendreon
 
Daniel Peter Petrylak
Stock and Other Ownership Interests - Bellicum Pharmaceuticals; TYME
Honoraria - Astellas Pharma; Bayer; Bellicum Pharmaceuticals; Exelixis; Ferring; Genentech; Johnson & Johnson; Medivation; Merck Serono; Millennium; Pfizer; Progenics; Sanofi
Consulting or Advisory Role - Bayer; Bellicum Pharmaceuticals; Dendreon; Exelixis; Ferring; Johnson & Johnson; Medivation; Millennium; Pfizer; Sanofi
Research Funding - Astellas Medivation; Dendreon; Endocyte; Genentech; gtx; Johnson & Johnson; Merck; Millennium; Novartis; Oncogenex; progenics; Progenics; Sanofi
Expert Testimony - Celgene; sanofi
Travel, Accommodations, Expenses - Bayer; Bellicum Pharmaceuticals; Celgene; Dendreon; Exelixis; Ferring; Johnson & Johnson; Medivation; Millennium; Oncogenex; Pfizer; Progenics; Sanofi